OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
BDMD Baird Medical Investment Holdings
- 5.210
- -0.300-5.44%
Close Mar 31 16:00 ET
- 5.250
- +0.040+0.77%
Post 18:13 ET
189.45MMarket Cap130.25P/E (TTM)
5.965High5.062Low40.76KVolume5.470Open5.510Pre Close217.43KTurnover0.38%Turnover Ratio130.25P/E (Static)36.36MShares13.52052wk High5.61P/B55.43MFloat Cap1.05052wk Low--Dividend TTM10.64MShs Float13.520Historical High--Div YieldTTM16.40%Amplitude1.050Historical Low5.334Avg Price1Lot Size
About Baird Medical Investment Holdings Company
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Company Profile
SymbolBDMD
Company NameBaird Medical Investment Holdings
Listing DateDec 13, 2021
Founded2023
CEOMs. Haimei Wu
MarketNASDAQ
Fiscal Year Ends12-31
AddressBaide Building, Building 11,No. 11 Rongtong Street,Room 202, 2nd Floor, Yuexiu District
CityGuangzhou
ProvinceGuangdong
CountryChina
Zip Code510000
Phone86-20-82185926
Company Executives
- Name
- Position
- Salary
- Haimei Wu
- Chairwoman of the Board and Chief Executive Officer
- --
- Quan Qiu
- Director and Chief Administrative Officer
- --
- Kun Seng Ng
- Chief Financial Officer and Company Secretary
- --
- Rongjian Lu
- Co-Chief Technical Officer and Deputy General Manager
- --
- Hailong Sun
- Co-Chief Technical Officer and Technical Department Manager
- --
- Wei Xu
- Merchandising Department Manager
- --
- Jin Xu
- Quality Assurance Department Manager
- --
- Jianwei Yuan
- Production Department Manager
- --
- Wei Hou
- Director, Vice General Manger and Director, Sales
- --
- Professor Dr. Mingzhao Michael Xing, M.D.
- Independent Director
- --
- Professor Dr. Jianguo Ma, PhD
- Independent Director
- --
- Steven T. Halverson
- Independent Director
- --
- Joseph Ragan
- Independent Director
- --
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings